APA (7th ed.) Citation

HH, J., KW, L., QY, C., XY, W., TJ, H., SJ, L., . . . ZL, F. (2018). High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China. Intervirology, 61(3), 123. https://doi.org/10.1159/000493797

Chicago Style (17th ed.) Citation

HH, Jia, et al. "High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China." Intervirology 61, no. 3 (2018): 123. https://doi.org/10.1159/000493797.

MLA (9th ed.) Citation

HH, Jia, et al. "High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China." Intervirology, vol. 61, no. 3, 2018, p. 123, https://doi.org/10.1159/000493797.